Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- Takeda Transfers Mizusawa Shares to Osaka Gas Chemicals for 4.3 Billion Yen
April 2, 2015
- SGLT-2 Inhibitors Represent Only 0.6% of Diabetes Prescriptions at DPC Hospitals: Survey
April 1, 2015
- Lupin Group’s Kyowa Sees Japan-India Collaboration as Key to Survival: Pres.
April 1, 2015
- Takecab Ranks 1st for Second Month in a Row: Anterio February Ranking
April 1, 2015
- Ajinomoto, Kissei Tie Up to Develop, Market Ulcerative Colitis Treatments
April 1, 2015
- Denka Seiken Develops Prototype of Rapid Diagnostic Agent for Ebola Virus
April 1, 2015
- Fujifilm to Buy US iPS Cell Manufacturer Cellular Dynamics
March 31, 2015
- Eisai’s Lenvima Gains Positive Opinion from CHMP
March 31, 2015
- Taisho Partners with Teijin to Comarket Patch Formulation Containing S-Flurbiprofen
March 31, 2015
- Hisamitsu to Rejuvenate Management with Nakatomi Junior as President
March 30, 2015
- Ichiro Otsuka Becomes Chairman of Otsuka Holdings
March 30, 2015
- Pfizer Looking for Drug Discovery Partnerships with Domestic Drug Makers
March 30, 2015
- Genzyme Japan Receives Approval for Japan’s 1st Oral Gaucher’s Disease Treatment Cerdelga
March 30, 2015
- E Keppra Filed for Generalized Tonic-Clonic Seizures: Otsuka, UCB Japan
March 30, 2015
- Takeda Seeks Japan Approval for Single-Packs Containing Takecab for H. pylori Eradication
March 27, 2015
- Sovaldi, Oral, Interferon-Free Treatment, Approved for Chronic HCV Infection in Japan: Gilead Sciences
March 27, 2015
- Xtandi Significantly Extends OS, Lowers Risk of Death by 23%
March 26, 2015
- Santen Ups FY2014 Financial Outlook on Merck Asset Acquisition
March 26, 2015
- Sun Pharma Completes Merger with Ranbaxy; Daiichi Sankyo Owns 9% Share in Combined Firm
March 26, 2015
- Yoshiki Ito to Lead Merged Entity of Allergan, Actavis in Japan
March 25, 2015
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…